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Abstract
Background
Declines in HIV prevalence and increases in antiretroviral treatment coverage have been
documented in Kenya, but population-level mortality associated with HIV has not been
directly measured. In urban areas where a majority of deaths pass through mortuaries, mor-
tuary-based studies have the potential to contribute to our understanding of excess mortality
among HIV-infected persons. We used results from a cross-sectional mortuary-based HIV
surveillance study to estimate the association between HIV and mortality for Nairobi, the
capital city of Kenya.
Methods and findings
HIV seropositivity in cadavers measured at the two largest mortuaries in Nairobi was used
to estimate HIV prevalence in adult deaths. Model-based estimates of the HIV-infected and
uninfected population for Nairobi were used to calculate a standardized mortality ratio and
population-attributable fraction for mortality among the infected versus uninfected popula-
tion. Monte Carlo simulation was used to assess sensitivity to epidemiological assumptions.
When standardized to the age and sex distribution of expected deaths, the estimated HIV
positivity among adult deaths aged 15 years and above in Nairobi was 20.9% (95% CI 17.7–
24.6%). The standardized mortality ratio of deaths among HIV-infected versus uninfected
adults was 4.35 (95% CI 3.67–5.15), while the risk difference was 0.016 (95% CI 0.013–
0.019). The HIV population attributable mortality fraction was 0.161 (95% CI 0.131–0.190).
Sensitivity analyses demonstrated robustness of results.
Conclusions
Although 73.6% of adult PLHIV receive antiretrovirals in Nairobi, their risk of death is
four-fold greater than in the uninfected, while 16.1% of all adult deaths in the city can be
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Introduction
Access to antiretroviral treatment (ART) has increased from 1 million to 17 million people liv-
ing with HIV (PLHIV) globally from 2003 to 2015 [1, 2]. High HIV burden countries have
accounted for the majority of this scale-up, with the number of PLHIV on ART increasing
from 4 million to over 10 million in the last 5 years in Eastern and Southern Africa [3]. In both
high- and low-income countries ART substantially increases life expectancy, especially for
patients who start ART early [4, 5]. Given the rapid increase in coverage of life-saving treat-
ment, a commensurate decrease in mortality in HIV-infected populations in high-burden
countries would be expected. While cohort studies have demonstrated reductions in mortality
among patients accessing ART, high rates of loss to follow-up (LTFU) make it difficult to fully
assess the impact of ART at the population level. Complementary surveillance systems that can
systematically assess population impact of ART programs on all-cause mortality on an ongoing
basis are needed.
Civil registration systems in developing countries are often incomplete and causes of death
poorly characterized. While a large fraction of PLHIV may be enrolled in care, high levels of
LTFU, undocumented transfers, and passive reporting of deaths mean that program data
underestimate mortality in the population in care if not linked to vital statistics [6] or adjusted
statistically with LTFU studies [7, 8]. Hospital-based surveillance can shed light on HIV mor-
tality among hospitalized patients, when both testing and HIV surveillance are routinely con-
ducted [9]. Disease case surveillance systems, which could link patient records across systems,
are still in their infancy in these settings. Further, the population in care is likely to have
reduced mortality compared with those not in care, due to having access to medical
interventions.
In urban areas where a majority of cadavers pass through mortuaries, mortuary-based stud-
ies have the potential to contribute to our understanding of excess mortality among HIV-
infected persons. Although the literature is sparse on use of HIV testing in mortuary settings
for surveillance purposes, De Cock et al. conducted a mortuary-based study to estimate mor-
tality rates due to HIV and AIDS in Abidjan, Cote D’Ivoire in the late 1980s, before effective
treatment for HIV existed, demonstrating that HIV was the leading cause of death in the city
at the time [10]. A similar study conducted in 2001 found that nearly half of adult deaths in
Pointe-Noire, Republic of Congo could be attributed to HIV, while the City of New York has
been routinely testing for HIV during autopsies since the early 1990’s [11]. In Addis Ababa,
Ethiopia, mortality surveillance at burial grounds demonstrated reductions in AIDS-related
mortality following scale-up of ART [12].
Coverage of ART has rapidly expanded in Kenya, reaching 59% of all PLHIV by the end of
2014 [3], and is likely to be highest in the capital city of Nairobi. The high estimated coverage
of death registration in Nairobi at 78% in 2014 [13], together with the fact that all registered
deaths in Nairobi are notified by mortuaries, implies that mortuary-based surveillance could
be representative of all deaths in the city. Relatively high ART coverage among PLHIV coupled
with high levels of mortuary-based death registration and moderate HIV prevalence in adults,
made Nairobi an attractive site for examining HIV-related adult mortality. We conducted a
cross-sectional mortuary-based serological study to measure HIV prevalence among deaths in
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Nairobi. We used results from this study to estimate the population-level association between
HIV and mortality for the city of Nairobi in the era of scale-up of ART towards universal
access.
Materials and methods
Mortuary HIV surveillance
The two largest mortuaries in Nairobi in terms of admissions volume were selected for HIV
mortuary surveillance. Kenyatta National Hospital (KNH) is a national teaching and referral
hospital and its mortuary saw 9,272 admissions in 2014. In contrast, City Mortuary saw 5,253
admissions in 2014 and primarily receives cadavers brought by the police in addition to cases
from smaller health facilities lacking a mortuary. All cadavers admitted to KNH and City Mor-
tuary over a 33 day period from 29 January to 3 March 2015 were registered. Cadavers of per-
sons aged 15 years and above at death were sampled using transthoracic aspiration of cardiac
blood which was shipped within 6 hours to a central laboratory for processing. Plasma was
tested using the national HIV diagnostic algorithm. Specimens were screened with Colloidal
Gold assay (KHB Shanghai Kehua Bio-Engineering Co, LTD, Shanghai, China). Reactive
results were confirmed using First Response HIV 1-2-0 assay (PMC Medical India Pvt Ltd,
Mumbai, India). Specimens with discrepant results were tested with Uni-Gold HIV assay as a
tie breaker (Trinity Biotech PLC, Bray, Ireland) and the result of the tie-breaker was taken as
the final result for the specimen. Every seventh specimen that was non-reactive on the screen-
ing assay was confirmed as an internal quality assurance step.
Nairobi Civil registration
To determine the proportion of annual deaths reported during the study period for City Mor-
tuary, KNH, and city-wide, as well as the proportion of deaths reported by each mortuary and
seasonal variation of reported deaths, we abstracted death notifications from the Vital Statistics
office at Nairobi City Hall for adults aged 15 and above at time of death for all deaths reported
in Nairobi in 2014. We extracted summary data of total deaths by age, sex and year for Nairobi
from the 2014 annual vital statistics report for purposes of estimating the age/sex distribution
of deaths in Nairobi. These data were used to assess the coverage of death reporting in Nairobi
as well as the coverage of City and KNH mortuaries among all reported deaths.
Measures
Age and sex of cadavers in the mortuary study were based on the reported age and sex from
the death notification, the sex, date of birth and age recorded in the patient medical records
if the death occurred at Kenyatta National Hospital and medical records were available for
abstraction, or the autopsy report completed by the pathologist. Age and sex of deaths reported
to vital statistics were based on the age and sex recorded on the death notification.
Population projections
Spectrum version 5.52b3 (Avenir Health, Glastonbury, Connecticut) was used to estimate
ART program coverage, HIV-related mortality, as well as the age- and sex-specific HIV preva-
lence for Nairobi in 2015, based on official demographic statistics, HIV surveillance and pro-
gram data and population-based survey data for Nairobi [14–17]. The age and sex distribution
of HIV prevalence from Spectrum was applied to the sub-national population projection for
Nairobi from the Kenya National Bureau of Statistics [18] to estimate the number of people
living with and without HIV in Nairobi in 2015. A life table derived from the Spectrum
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projection for Nairobi was used to estimate age-specific mortality rates. The projection is sum-
marized in S1 Table.
Analysis methods
Data were logged into an Epi Info version 7.0.4 database (U.S. Centers for Disease Control and
Prevention [CDC], Atlanta). Data cleaning, tabulation and statistical analyses were performed
in Stata version 13 (Stata Corp., College Station, Texas). Coverage and representativeness of
surveillance system deaths were assessed by plotting reported versus expected deaths by year
and by age group and sex. Inverse probability weights were developed and used to adjust the
observed deaths from the surveillance system to account for missing HIV status by age and
sex, and mortuary population weights were developed to adjust for differences in age- and sex-
specific coverage and annualize deaths with respect to expected deaths based on the KNBS
population projection and the Spectrum life table. Mortality rates were calculated by dividing
the weighted annualized deaths from the surveillance system by the estimated population size
in Nairobi from the population projection, by age, sex and HIV status, then multiplying by
1000.
The standardized risk difference subtracts the mortality rate in the HIV-uninfected popula-
tion from the corresponding rate in the HIV-infected population, by age and sex. It is an addi-
tive measure which describes the additional mortality burden in the HIV-infected population.
The standardized mortality ratio (SMR) is a relative measure which divides the mortality rate
in the infected population by the mortality rate in the uninfected population after standardiz-
ing to the age and sex distribution of the infected population. Both measures were calculated
using Stata’s epitab package.
The population attributable fraction (PAF) estimates the proportion of all deaths that
would have been avoided if HIV were no longer a risk factor for mortality in the HIV-infected.
Odds ratios were fit using logit models with population frequency rates normalized to the total
observed deaths, and these were then used to calculate attributable fractions with Stata’s punaf
command [19]. We also used logit models to test for interaction between age group and sex.
Simulation methods
Monte Carlo simulations were conducted to assess the sensitivity of risk ratio and attributable
fraction estimates to epidemiological assumptions; additional details are provided in S1 Text.
Data access
Data are available from the National AIDS & STI Control Programme (NASCOP), Ministry of
Health, Kenya on request. Requests for access should be directed to head@nascop.or.ke.
Ethics approvals
This public health surveillance activity was approved by the U.S. Centers for Disease Control
Center for Global Health as research that did not involve human subjects (because subjects
were deceased) and did not require institutional review board review for human experimenta-
tion [2014/062]. The Kenyatta National Hospital/University of Nairobi Ethical Review Com-
mittee also approved this study [P380/06/2014] and did not require consent from next of kin.
All data on deceased subjects were de-identified prior to data analysis.
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Results
We found a pooled, unadjusted HIV positivity rate of 19.5% (95% CI 16.5–22.9%) among
deaths at KNH and City Mortuaries, the positivity differing significantly by sex (14.6% among
men, 29.5% among women, p<0.001). After weighting to account for missing test results and
the coverage of the included mortuaries with respect to expected deaths by age and sex, the
estimated HIV positivity among adult deaths in Nairobi was 20.9% (95% CI 17.7–24.6%)
(Table 1).
A total of 807 deaths of persons aged 15 years and above (range 15–105 years, median 40
years) were reported during the 33 day period of data collection at the two mortuaries. These
corresponded to 8,320 deaths when annualized and seasonally-adjusted. Based on a demo-
graphic projection, there were 16,173 deaths of persons aged 15 years and above for Nairobi
City in 2015, indicating that after annualizing, the coverage of the sampled mortuaries was
65.0% of reported deaths, and 51.4% of expected deaths. Coverage versus expected deaths var-
ied substantially by age and sex from 22.2% for women aged 15–24 years to 63.5% for men
aged 25–44 years. Annualized deaths were then adjusted for this age- and sex-specific coverage
to obtain the total adjusted deaths (Table 2).
An estimated 2.8 million adults aged 15 years and above were residents of Nairobi in 2015,
corresponding to 160,386 HIV-infected and 2,649,060 HIV-uninfected adults based on an
overall HIV prevalence of 5.6% for Nairobi (Table 3). Dividing the estimated deaths from the
surveillance system by the total projected population, the crude mortality rate in Nairobi
among persons aged 15 years and older was 5.76 / 1,000 persons. In women, age-specific mor-
tality estimates ranged from 1.92 / 1,000 among those aged 15–24 to 16.70 / 1,000 among
women aged 45 and above. In men, mortality ranged from 3.16 / 1,000 among men aged 15–
24 to 17.41 among men aged 45 and above. Overall, the mortality rate among HIV-infected
persons was 21.12 / 1,000 compared with 4.83 / 1,000 among HIV-uninfected persons aged 15
years and older. Among HIV-infected women the mortality rate was 20.59 / 1,000 compared
with 21.89 / 1,000 among HIV-infected men (Table 3). The standardized mortality ratio was
4.35 (95% CI 3.67–5.15), indicating that risk of death was significantly higher among HIV-
infected persons compared with HIV-uninfected persons, when controlling for age and sex.
The standardized risk difference was 0.016 (95% CI 0.013–0.019), corresponding to 16 addi-
tional deaths per 1,000 population among the HIV-infected after adjusting for age and sex
(Table 4). The interaction between age and sex was significant, so all estimates were calculated
using models stratified by sex and age group.
Table 1. Percent HIV positivity among cadavers at City and KNH mortuaries, Nairobi 2015.
Sex Age (years) Unadjusted HIV-positivity (n = 610) (95% CI) Adjusted HIV-positivity (n = 807)* (95% CI)
Male 15–24 8.5 (3.2,20.6) 8.9 (3.3,21.7)
25–44 15.3 (11.1,20.8) 15.3 (11.1,20.8)
45 15.5 (10.5,22.3) 15.8 (10.7,22.7)
Total 14.6 (11.5,18.4) 14.8 (11.6,18.7)
Female 15–24 40.0 (19.1,65.4) 40.8 (19.6,66.1)
25–44 46.1 (36.0,56.5) 46.1 (35.8,56.7)
45 12.5 (7.2,20.8) 12.4 (7.2,20.7)
Total 29.5 (23.5,36.2) 30.2 (24.0,37.3)
Grand-total 19.5 (16.5,22.9) 20.9 (17.7,24.6)
Notes
* Adjusted for missing HIV test results and coverage of selected mortuaries by age and sex, assuming HIV status missing at random.
https://doi.org/10.1371/journal.pone.0181837.t001
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Combining the risk estimates with the prevalence of HIV in the population, the population
attributable fraction (PAF) was 0.161 (95% CI 0.131–0.190). The estimated PAF differed
between men and women, with women having a higher PAF for HIV infection than men: the
PAF for women was 0.254 and for men was 0.101 (Table 4).
There were 40,382 males and 77,640 females aged 15 years and above on ART in Nairobi by
December 31, 2015 according to official HIV program statistics. The Spectrum ART coverage
estimate for 2015 for all HIV-infected persons aged 15 or more years in Nairobi was 73.6%,
61.1% for males and 82.3% for females, and Spectrum predicted that 13.8% of male deaths and
8.3% of female deaths (11.4% combined) would have been HIV-infected in 2015 (S1 Table).
Our sensitivity analysis looked at several key parameters that were estimated for this analy-
sis as presented in S2 Table. The outcomes were most sensitive to HIV prevalence in the
mortuaries and in the population, as well as the ratio of observed to unobserved prevalence in
the mortuaries. The uncertainty interval for the SMR obtained through the uncertainty analy-
sis was 3.04–7.19, while for the PAF the uncertainty interval was 0.118–0.221 (S3 Table).
Table 2. Annualized and coverage-adjusted surveillance deaths, Nairobi 2015.
Sex Age
(years)
Observed
mortuary
deaths *
Annualized
mortuary deaths
†
Registered
deaths in
Nairobi ‡
Estimated
coverage of
registered deaths
Expected
deaths for
Nairobi §
Estimated
coverage of
expected deaths
Adjusted
mortuary
deaths ¶
Male 15–24 61 629 846 74.3% 1,059 59.4% 53
25–44 277 2,856 3,124 91.4% 4,497 63.5% 225
45+ 197 2,031 3,552 57.2% 4,168 48.7% 209
Total 535 5,515 7,522 73.3% 9,724 56.7% 486
Female 15–24 19 196 491 39.9% 881 22.2% 42
25–44 123 1,268 2,076 61.1% 2,681 47.3% 134
45+ 130 1,340 2,707 49.5% 2,887 46.4% 144
Total 272 2,804 5,274 53.2% 6,449 43.5% 321
Grand-
total
807 8,320 12,796 65.0% 16,173 51.4% 807
Notes: Some totals do not match sum of rows due to rounding errors.
* Deaths registered at KNH and City Mortuaries during the study period.
† Deaths from study sites annualized based on seasonally-adjusted study period of 0.097 years.
‡ Deaths registered at Nairobi City Hall in calendar year 2014.
§ Expected deaths based on Kenya National Bureau of Statistics (KNBS) projection and Spectrum life table for Nairobi.
¶ Deaths annualized and adjusted for differential coverage by age and sex with respect to expected deaths for Nairobi.
https://doi.org/10.1371/journal.pone.0181837.t002
Table 3. Estimated age- and sex-specific deaths, population, and mortality rates per 1000 population, Nairobi 2015.
Age (Years) HIV-negative HIV-positive Total
Sex deaths / pop (rate) deaths / pop (rate) deaths / pop (rate)
Male 15–24 967/330,458 (2.93) 95/6,011 (15.80) 1,062/336,469 (3.16)
25–44 3,818/767,352 (4.98) 691/46,156 (14.97) 4,509/813,508 (5.54)
45+ 3,518/226,141 (15.56) 660/13,885 (47.53) 4,178/240,026 (17.41)
Total 8,303/1,323,951 (6.27) 1446/66,052 (21.89) 9,749/1,390,003 (7.01)
Female 15–24 499/424,695 (1.17) 344/13,607 (25.28) 843/438,302 (1.92)
25–44 1,449/737,582 (1.96) 1238/70,315 (17.61) 2,687/807,897 (3.33)
45+ 2534/162,832 (15.56) 360/10,412 (34.58) 2,894/173,244 (16.70)
Total 4,482/1,325,109 (3.38) 1,942/94,334 (20.59) 6,424/1,419,443 (4.53)
Overall 12,785/2,649,060 (4.83) 3,388/160,386 (21.12) 16,173/2,809,446 (5.76)
https://doi.org/10.1371/journal.pone.0181837.t003
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Discussion
We conducted an analysis to combine HIV prevalence in a sample of deaths in Nairobi with
population estimates in order to assess the burden of mortality associated with HIV in adults.
We believe this is the first African study of its kind in the era of ART scale-up and as such it
provides important insights in to the association of mortality and HIV infection in a major
urban center with generalized HIV prevalence and a public ART program that reaches the
majority of adults living with HIV. People living with HIV are at risk from death from multiple
competing causes, including HIV. By estimating measures such as the SMR, RD and PAF this
study looks beyond disease prevalence and provides estimates of the continuing impact of
HIV on the adult population of Nairobi. Despite 7 in 10 HIV-infected persons aged 15 years
and above receiving ART, our study showed persons living with HIV had a four-fold increased
risk of mortality compared with those not infected. The population attributable fraction of
0.161 shows that about one in six deaths would be avoided in Nairobi if the increased mortality
associated with HIV infection were eliminated, and more deaths would potentially be avoided
in women than in men.
Antiretroviral treatment has been shown to dramatically reduce premature mortality. A
prior study in Central Africa conducted at the height of the HIV epidemic when HIV preva-
lence was similar to Nairobi, but before ART was widely available, found nearly half of adult
deaths were HIV-infected, while an East African cohort study in the late 1990’s found a
20-fold increased mortality risk among the HIV-infected before widespread access to ART. A
national study in South Africa found consistent declines in population all-cause mortality asso-
ciated with early expansion of ART access from 2005–2009. In our study, conducted after over
a decade of ART scale-up, we found about 1 in 5 deaths was HIV-infected, yet people living
with HIV continue to be at significantly increased risk of death with a greater than four-fold
increased risk of mortality. This is especially true for women in Nairobi who have reached
82.3% ART coverage in 2015 –surpassing the UNAIDS fast-track target of 81% of all PLHIV
on treatment.
This study had several limitations. The mortality data were collected in early 2015, but the
distribution of deaths available for abstraction at the time of the study was for 2014. The cover-
age of the two participating mortuaries was moderate, but may not have been representative of
all deaths in the city. The calculation of mortality rates assumes that measured deaths were
from the resident population, however deaths in Nairobi are not necessarily drawn from the
resident population of the city. Some Nairobi residents die outside the city limits, and some
non-Nairobi residents die within the city. The latter group is likely to be over-represented at
KNH since it is a national referral hospital and routinely receives patients transferred from
other counties.
Although these two facilities do not include all deaths in the city, they do include a signifi-
cant fraction of deaths that occur in Nairobi. Although there may be some seasonal factors that
affect mortality, Nairobi does not generally suffer from seasonal malaria epidemics or other
Table 4. Risk difference (RD), standardized mortality rate (SMR) and population attributable fraction (PAF) due to HIV, Nairobi 2015.
Sex
Male Female Total
Statistic Estimate (95% CI) Estimate (95% CI) Estimate (95% CI)
SMR 3.12 (2.43–3.99) 6.17 (4.86–7.83) 4.35 (3.67–5.15)
RD 0.015 (0.010–0.020) 0.017 (0.013–0.021) 0.016 (0.013–0.019)
PAF 0.101 (0.067–0.133) 0.254 (0.199–0.305) 0.161 (0.131–0.190)
https://doi.org/10.1371/journal.pone.0181837.t004
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infectious disease outbreaks that are likely to be over- or under-represented during the study
period. After seasonal and annual adjustments for total deaths, our study covered 51.4% of
expected deaths based on demographic estimates, but covered 65.0% of reported deaths, but
coverage varied substantially by age and sex. Our sensitivity analysis found that outcome mea-
sures were sensitive to assumptions about HIV prevalence and representativeness of sampled
mortuaries, however our uncertainty analysis showed that overall conclusions were robust in
the face of this uncertainty, lending confidence in the robustness of the findings that the risk of
dying is greater in the HIV-infected population than in the HIV-uninfected population, and
that a considerable fraction of deaths at the population level can be attributed to HIV in
Nairobi.
Though a lower proportion of HIV-infected men access treatment, their lower HIV preva-
lence and competing causes of mortality result in HIV being a less frequent cause of death. A
complete diagnosis, treatment and adherence history for all deaths could help elucidate to
what extent undiagnosed infection, inadequate treatment access or late presentation, poor
adherence, or treatment failure are responsible for the mortality differentials seen among
PLHIV. Mathematical modeling has shown that the majority of deaths among PLHIV are
likely to be among those not on treatment, even in high ART coverage settings, underscoring
the need to reduce barriers to treatment initiation and improve retention on ART. Thus it was
surprising to find a higher HIV-associated SMR among women than men, in spite of their
greater access to ART. This may be due to over-representation of deaths due to external causes
in our sample, which differentially affect men. If this is the case, our estimates of HIV mortality
among men are conservative. Inclusion of additional mortuaries in future studies would help
control this potential bias. Despite study limitations, it appears that mortality among PLHIV
in Nairobi continues to be high in spite of high estimated ART treatment coverage. This high
mortality among PLHIV may help explain why HIV prevalence has not increased in recent
years in spite of continued new infections and a rapid expansion of public HIV care and treat-
ment services [20].
Conclusion
Although sub-Saharan Africa has dramatically decreased mortality due to HIV through expan-
sion of ART, in order to further reduce HIV-associated mortality, high-burden countries may
need to reach very high levels of diagnosis, treatment coverage, retention in care, and viral sup-
pression. Though hospitals are no longer overwhelmed with AIDS patients, Kenya has not yet
achieved the goal of an AIDS-free generation.
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